PL1989182T3 - Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające - Google Patents
Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierająceInfo
- Publication number
- PL1989182T3 PL1989182T3 PL07731039.9T PL07731039T PL1989182T3 PL 1989182 T3 PL1989182 T3 PL 1989182T3 PL 07731039 T PL07731039 T PL 07731039T PL 1989182 T3 PL1989182 T3 PL 1989182T3
- Authority
- PL
- Poland
- Prior art keywords
- perindopril
- preparing
- pharmaceutical compositions
- crystalline form
- arginine salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0601748A FR2897866B1 (fr) | 2006-02-28 | 2006-02-28 | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1989182T3 true PL1989182T3 (pl) | 2016-09-30 |
Family
ID=37022969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07731039.9T PL1989182T3 (pl) | 2006-02-28 | 2007-02-26 | Postać krystaliczna soli peryndoprylu z argininą, sposób jej wytwarzania i kompozycje farmaceutyczne ją zawierające |
Country Status (28)
Country | Link |
---|---|
US (1) | US7846961B2 (pl) |
EP (1) | EP1989182B1 (pl) |
JP (1) | JP5255454B2 (pl) |
KR (2) | KR20120001818A (pl) |
CN (1) | CN101389603B (pl) |
AU (1) | AU2007220435B2 (pl) |
BR (1) | BRPI0708278B8 (pl) |
CA (1) | CA2644467C (pl) |
CY (1) | CY1117753T1 (pl) |
DK (1) | DK1989182T3 (pl) |
EA (1) | EA014716B1 (pl) |
ES (1) | ES2581982T3 (pl) |
FR (1) | FR2897866B1 (pl) |
GE (1) | GEP20125433B (pl) |
HK (1) | HK1129669A1 (pl) |
HR (1) | HRP20160644T1 (pl) |
HU (1) | HUE027898T2 (pl) |
MA (1) | MA30276B1 (pl) |
ME (1) | ME02456B (pl) |
MY (1) | MY151035A (pl) |
NO (1) | NO20083535L (pl) |
NZ (1) | NZ570367A (pl) |
PL (1) | PL1989182T3 (pl) |
RS (1) | RS54754B1 (pl) |
SI (1) | SI1989182T1 (pl) |
UA (1) | UA89905C2 (pl) |
WO (1) | WO2007099217A1 (pl) |
ZA (1) | ZA200807024B (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2729604C (en) * | 2008-06-24 | 2017-12-05 | Matrix Laboratories Ltd. | Polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
AU2009212902A1 (en) | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
SI23149A (sl) | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
FR2985511B1 (fr) | 2012-01-05 | 2014-01-03 | Servier Lab | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
FR2985512B1 (fr) | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
CN103172696B (zh) * | 2012-12-19 | 2014-12-17 | 宁波美诺华药业股份有限公司 | 一种γ晶型的培哚普利精氨酸盐的制备方法 |
FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
EP3842035A1 (en) | 2019-12-23 | 2021-06-30 | KRKA, d.d., Novo mesto | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules |
SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
CN114149357B (zh) * | 2021-12-29 | 2024-06-25 | 江苏嘉逸医药有限公司 | 一种γ晶型培哚普利精氨酸盐的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
FR2811319B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2811318B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
FR2838648B1 (fr) * | 2002-04-18 | 2004-05-21 | Servier Lab | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
FR2897865B1 (fr) | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
CA2729604C (en) | 2008-06-24 | 2017-12-05 | Matrix Laboratories Ltd. | Polymorphic forms of perindopril (l)-arginine and process for the preparation thereof |
-
2006
- 2006-02-28 FR FR0601748A patent/FR2897866B1/fr active Active
-
2007
- 2007-02-26 PL PL07731039.9T patent/PL1989182T3/pl unknown
- 2007-02-26 AU AU2007220435A patent/AU2007220435B2/en active Active
- 2007-02-26 BR BRPI0708278A patent/BRPI0708278B8/pt active IP Right Grant
- 2007-02-26 GE GEAP200710918A patent/GEP20125433B/en unknown
- 2007-02-26 JP JP2008556812A patent/JP5255454B2/ja active Active
- 2007-02-26 DK DK07731039.9T patent/DK1989182T3/en active
- 2007-02-26 RS RS20160321A patent/RS54754B1/sr unknown
- 2007-02-26 MY MYPI20082991 patent/MY151035A/en unknown
- 2007-02-26 EA EA200801777A patent/EA014716B1/ru unknown
- 2007-02-26 UA UAA200811436A patent/UA89905C2/ru unknown
- 2007-02-26 ES ES07731039.9T patent/ES2581982T3/es active Active
- 2007-02-26 NZ NZ570367A patent/NZ570367A/en unknown
- 2007-02-26 HU HUE07731039A patent/HUE027898T2/en unknown
- 2007-02-26 KR KR1020117028452A patent/KR20120001818A/ko active Search and Examination
- 2007-02-26 ZA ZA200807024A patent/ZA200807024B/xx unknown
- 2007-02-26 US US12/224,369 patent/US7846961B2/en active Active
- 2007-02-26 KR KR1020087023638A patent/KR20080106948A/ko not_active Application Discontinuation
- 2007-02-26 CN CN2007800061889A patent/CN101389603B/zh active Active
- 2007-02-26 EP EP07731039.9A patent/EP1989182B1/fr not_active Revoked
- 2007-02-26 CA CA2644467A patent/CA2644467C/fr not_active Expired - Fee Related
- 2007-02-26 WO PCT/FR2007/000335 patent/WO2007099217A1/fr active Application Filing
- 2007-02-26 ME MEP-2016-140A patent/ME02456B/me unknown
- 2007-02-26 SI SI200731781A patent/SI1989182T1/sl unknown
-
2008
- 2008-08-14 NO NO20083535A patent/NO20083535L/no not_active Application Discontinuation
- 2008-09-11 MA MA31232A patent/MA30276B1/fr unknown
-
2009
- 2009-08-24 HK HK09107755.1A patent/HK1129669A1/xx unknown
-
2016
- 2016-06-09 HR HRP20160644TT patent/HRP20160644T1/hr unknown
- 2016-07-11 CY CY20161100654T patent/CY1117753T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1989182T1 (sl) | Kristalinična oblika argininske soli perindoprila, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo | |
PL1752443T3 (pl) | Nowa postać krystaliczna V agomelatyny, sposób jej wytwarzania i kompozycje farmaceutyczne, które ją zawierają | |
SI2210872T1 (sl) | Nova kristalinična oblika iii agomelatina, postopek za njeno pripravo in farmacevtski sestavki, ki jo vsebujejo | |
ME02750B (me) | Kristalni oblik gama - d iv abradin hlorhidrata, postupak njegove izrade i farmaceutske smeše koje ga sadrže | |
IL212464A0 (en) | Process for the preparation of protected l-alanine derivatives | |
IL198847A0 (en) | New process for the preparation of 2-imino-thiazolidin-4-one derivatives | |
IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
HUP0600808A3 (en) | New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them | |
EP2038282A4 (en) | SALTS OF PYRROLOPYRIMIDINONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | |
IL218539A (en) | Annotated 4,1-Androsteadian-3-Oxo-9,6-Dihlo-16-Isoxazolidine-17-Noble N-Converted | |
IL188069A0 (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
HUP0600293A3 (en) | Zinc salt of rosuvastatine, process for its preparation and pharmaceutical compositions containing it | |
SI1707564T1 (sl) | Indanil-piperazinski derivati, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo | |
SI2231598T1 (sl) | Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki | |
EP2212325A4 (en) | 2-ARYLMETHYLAZETIDINCARBAPENEM-3-CARBOXYLENE DERTERIVATE OR SALT, METHOD FOR THE PRODUCTION THEREOF AND THEREOF COMPRISING PHARMACEUTICAL COMPOSITION | |
PT1753720E (pt) | Processo para a preparação de perindopril e sais do mesmo | |
IL205082A0 (en) | Process for the preparation of tetranorlabdane derivatives | |
ZA200902414B (en) | Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
HUP0700756A2 (en) | Process for the preparation of pharmaceutical intermediers | |
EP2222624A4 (en) | 4-NEROLIDYLCATECHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THESE DERIVATIVES AND PREPARATION METHOD THEREOF | |
ZA200902413B (en) | Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them | |
ZA200806713B (en) | Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same | |
SG125975A1 (en) | New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it | |
SG125974A1 (en) | New beta crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it | |
SG125976A1 (en) | New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it |